Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2025-02-13 4:30 pm Purchase |
2024-12-31 | 13G | Corvus Pharmaceuticals, Inc. CRVS |
MILLER RICHARD A MD | 5,220,368 7.700% |
1,536,358![]() (+41.70%) |
Filing History |
2024-02-13 6:27 pm Purchase |
2023-12-31 | 13G | Corvus Pharmaceuticals, Inc. CRVS |
MILLER RICHARD A MD | 3,684,010 7.190% |
578,889![]() (+18.64%) |
Filing History |
2023-02-10 4:00 pm Purchase |
2022-12-31 | 13G | Corvus Pharmaceuticals, Inc. CRVS |
MILLER RICHARD A MD | 3,105,121 6.450% |
497,973![]() (+19.10%) |
Filing History |
2022-02-11 5:55 pm Purchase |
2021-12-31 | 13G | Corvus Pharmaceuticals, Inc. CRVS |
MILLER RICHARD A MD | 2,607,148 5.450% |
427,589![]() (+19.62%) |
Filing History |
2021-02-12 9:18 pm Purchase |
2020-12-31 | 13G | Corvus Pharmaceuticals, Inc. CRVS |
MILLER RICHARD A MD | 2,179,559 7.500% |
220,417![]() (+11.25%) |
Filing History |